Logo image of MELE.BR

MELEXIS NV (MELE.BR) Stock Fundamental Analysis

EBR:MELE - Euronext Brussels - BE0165385973 - Common Stock - Currency: EUR

58.75  -1 (-1.67%)

Fundamental Rating

6

MELE gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 58 industry peers in the Semiconductors & Semiconductor Equipment industry. MELE gets an excellent profitability rating and is at the same time showing great financial health properties. MELE has a correct valuation and a medium growth rate. MELE also has an excellent dividend rating. This makes MELE very considerable for dividend investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year MELE was profitable.
In the past year MELE had a positive cash flow from operations.
Each year in the past 5 years MELE has been profitable.
Each year in the past 5 years MELE had a positive operating cash flow.
MELE.BR Yearly Net Income VS EBIT VS OCF VS FCFMELE.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M

1.2 Ratios

MELE has a Return On Assets of 23.42%. This is amongst the best in the industry. MELE outperforms 96.55% of its industry peers.
Looking at the Return On Equity, with a value of 37.69%, MELE belongs to the top of the industry, outperforming 82.76% of the companies in the same industry.
MELE's Return On Invested Capital of 27.13% is amongst the best of the industry. MELE outperforms 91.38% of its industry peers.
MELE had an Average Return On Invested Capital over the past 3 years of 33.81%. This is significantly above the industry average of 16.14%.
The last Return On Invested Capital (27.13%) for MELE is well below the 3 year average (33.81%), which needs to be investigated, but indicates that MELE had better years and this may not be a problem.
Industry RankSector Rank
ROA 23.42%
ROE 37.69%
ROIC 27.13%
ROA(3y)28.86%
ROA(5y)23.4%
ROE(3y)37.54%
ROE(5y)30.95%
ROIC(3y)33.81%
ROIC(5y)27.09%
MELE.BR Yearly ROA, ROE, ROICMELE.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30 40

1.3 Margins

The Profit Margin of MELE (21.15%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of MELE has remained more or less at the same level.
The Operating Margin of MELE (26.43%) is better than 63.79% of its industry peers.
In the last couple of years the Operating Margin of MELE has grown nicely.
MELE has a worse Gross Margin (44.77%) than 62.07% of its industry peers.
MELE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 26.43%
PM (TTM) 21.15%
GM 44.77%
OM growth 3Y23.02%
OM growth 5Y2.32%
PM growth 3Y16.74%
PM growth 5Y1.39%
GM growth 3Y6.54%
GM growth 5Y0.36%
MELE.BR Yearly Profit, Operating, Gross MarginsMELE.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30 40

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so MELE is creating value.
Compared to 1 year ago, MELE has about the same amount of shares outstanding.
Compared to 5 years ago, MELE has more shares outstanding
Compared to 1 year ago, MELE has a worse debt to assets ratio.
MELE.BR Yearly Shares OutstandingMELE.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
MELE.BR Yearly Total Debt VS Total AssetsMELE.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 7.65 indicates that MELE is not in any danger for bankruptcy at the moment.
MELE has a better Altman-Z score (7.65) than 70.69% of its industry peers.
MELE has a debt to FCF ratio of 3.41. This is a good value and a sign of high solvency as MELE would need 3.41 years to pay back of all of its debts.
MELE has a Debt to FCF ratio (3.41) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.43 indicates that MELE is not too dependend on debt financing.
The Debt to Equity ratio of MELE (0.43) is worse than 65.52% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 3.41
Altman-Z 7.65
ROIC/WACC2.55
WACC10.64%
MELE.BR Yearly LT Debt VS Equity VS FCFMELE.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M

2.3 Liquidity

A Current Ratio of 4.70 indicates that MELE has no problem at all paying its short term obligations.
With an excellent Current ratio value of 4.70, MELE belongs to the best of the industry, outperforming 87.93% of the companies in the same industry.
A Quick Ratio of 2.02 indicates that MELE has no problem at all paying its short term obligations.
MELE has a Quick ratio of 2.02. This is in the better half of the industry: MELE outperforms 77.59% of its industry peers.
Industry RankSector Rank
Current Ratio 4.7
Quick Ratio 2.02
MELE.BR Yearly Current Assets VS Current LiabilitesMELE.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

4

3. Growth

3.1 Past

MELE shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.39%.
MELE shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 12.69% yearly.
The Revenue has been growing slightly by 5.14% in the past year.
MELE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.11% yearly.
EPS 1Y (TTM)-4.39%
EPS 3Y44.69%
EPS 5Y12.69%
EPS Q2Q%-10.64%
Revenue 1Y (TTM)5.14%
Revenue growth 3Y23.86%
Revenue growth 5Y11.11%
Sales Q2Q%-0.28%

3.2 Future

Based on estimates for the next years, MELE will show a small growth in Earnings Per Share. The EPS will grow by 2.94% on average per year.
The Revenue is expected to grow by 4.50% on average over the next years.
EPS Next Y-11.06%
EPS Next 2Y-20.13%
EPS Next 3Y-4.22%
EPS Next 5Y2.94%
Revenue Next Year-2.37%
Revenue Next 2Y-6.02%
Revenue Next 3Y0.34%
Revenue Next 5Y4.5%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MELE.BR Yearly Revenue VS EstimatesMELE.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B
MELE.BR Yearly EPS VS EstimatesMELE.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8

5

4. Valuation

4.1 Price/Earnings Ratio

MELE is valuated reasonably with a Price/Earnings ratio of 11.73.
Compared to the rest of the industry, the Price/Earnings ratio of MELE indicates a rather cheap valuation: MELE is cheaper than 82.76% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 29.35. MELE is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 17.78 indicates a rather expensive valuation of MELE.
MELE's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. MELE is cheaper than 60.34% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.10. MELE is around the same levels.
Industry RankSector Rank
PE 11.73
Fwd PE 17.78
MELE.BR Price Earnings VS Forward Price EarningsMELE.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

67.24% of the companies in the same industry are more expensive than MELE, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, MELE is valued a bit cheaper than 68.97% of the companies in the same industry.
Industry RankSector Rank
P/FCF 34.05
EV/EBITDA 8.39
MELE.BR Per share dataMELE.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The excellent profitability rating of MELE may justify a higher PE ratio.
A cheap valuation may be justified as MELE's earnings are expected to decrease with -4.22% in the coming years.
PEG (NY)N/A
PEG (5Y)0.92
EPS Next 2Y-20.13%
EPS Next 3Y-4.22%

7

5. Dividend

5.1 Amount

MELE has a Yearly Dividend Yield of 4.33%, which is a nice return.
Compared to an average industry Dividend Yield of 1.50, MELE pays a better dividend. On top of this MELE pays more dividend than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.33, MELE pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.33%

5.2 History

On average, the dividend of MELE grows each year by 10.76%, which is quite nice.
Dividend Growth(5Y)10.76%
Div Incr Years3
Div Non Decr Years6
MELE.BR Yearly Dividends per shareMELE.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

MELE pays out 71.64% of its income as dividend. This is not a sustainable payout ratio.
MELE's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP71.64%
EPS Next 2Y-20.13%
EPS Next 3Y-4.22%
MELE.BR Yearly Income VS Free CF VS DividendMELE.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M
MELE.BR Dividend Payout.MELE.BR Dividend Payout, showing the Payout Ratio.MELE.BR Dividend Payout.PayoutRetained Earnings

MELEXIS NV

EBR:MELE (3/7/2025, 7:00:00 PM)

58.75

-1 (-1.67%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-05 2025-02-05/amc
Earnings (Next)04-30 2025-04-30
Inst Owners16.78%
Inst Owner ChangeN/A
Ins Owners25.01%
Ins Owner ChangeN/A
Market Cap2.37B
Analysts76.67
Price Target67.41 (14.74%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.33%
Yearly Dividend3.5
Dividend Growth(5Y)10.76%
DP71.64%
Div Incr Years3
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.63%
Min EPS beat(2)-5.84%
Max EPS beat(2)9.1%
EPS beat(4)2
Avg EPS beat(4)-1.28%
Min EPS beat(4)-9.25%
Max EPS beat(4)9.1%
EPS beat(8)5
Avg EPS beat(8)0.43%
EPS beat(12)9
Avg EPS beat(12)5.67%
EPS beat(16)11
Avg EPS beat(16)7.05%
Revenue beat(2)0
Avg Revenue beat(2)-1.82%
Min Revenue beat(2)-1.97%
Max Revenue beat(2)-1.68%
Revenue beat(4)0
Avg Revenue beat(4)-1.81%
Min Revenue beat(4)-1.97%
Max Revenue beat(4)-1.66%
Revenue beat(8)2
Avg Revenue beat(8)-0.99%
Revenue beat(12)5
Avg Revenue beat(12)-0.25%
Revenue beat(16)7
Avg Revenue beat(16)5.85%
PT rev (1m)-11.34%
PT rev (3m)-16.36%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-0.83%
EPS NY rev (3m)-8.98%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.43%
Revenue NY rev (3m)-5.18%
Valuation
Industry RankSector Rank
PE 11.73
Fwd PE 17.78
P/S 2.41
P/FCF 34.05
P/OCF 15.56
P/B 4.29
P/tB 4.3
EV/EBITDA 8.39
EPS(TTM)5.01
EY8.53%
EPS(NY)3.3
Fwd EY5.62%
FCF(TTM)1.73
FCFY2.94%
OCF(TTM)3.78
OCFY6.43%
SpS24.42
BVpS13.7
TBVpS13.67
PEG (NY)N/A
PEG (5Y)0.92
Profitability
Industry RankSector Rank
ROA 23.42%
ROE 37.69%
ROCE 32.79%
ROIC 27.13%
ROICexc 28.51%
ROICexgc 28.56%
OM 26.43%
PM (TTM) 21.15%
GM 44.77%
FCFM 7.06%
ROA(3y)28.86%
ROA(5y)23.4%
ROE(3y)37.54%
ROE(5y)30.95%
ROIC(3y)33.81%
ROIC(5y)27.09%
ROICexc(3y)43.58%
ROICexc(5y)35.39%
ROICexgc(3y)43.98%
ROICexgc(5y)35.8%
ROCE(3y)40.87%
ROCE(5y)32.75%
ROICexcg growth 3Y9.03%
ROICexcg growth 5Y-4.71%
ROICexc growth 3Y9.58%
ROICexc growth 5Y-4.43%
OM growth 3Y23.02%
OM growth 5Y2.32%
PM growth 3Y16.74%
PM growth 5Y1.39%
GM growth 3Y6.54%
GM growth 5Y0.36%
F-Score3
Asset Turnover1.11
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF 3.41
Debt/EBITDA 0.77
Cap/Depr 180.13%
Cap/Sales 8.4%
Interest Coverage 28.53
Cash Conversion 49.72%
Profit Quality 33.4%
Current Ratio 4.7
Quick Ratio 2.02
Altman-Z 7.65
F-Score3
WACC10.64%
ROIC/WACC2.55
Cap/Depr(3y)128.48%
Cap/Depr(5y)98.75%
Cap/Sales(3y)6.89%
Cap/Sales(5y)6.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.39%
EPS 3Y44.69%
EPS 5Y12.69%
EPS Q2Q%-10.64%
EPS Next Y-11.06%
EPS Next 2Y-20.13%
EPS Next 3Y-4.22%
EPS Next 5Y2.94%
Revenue 1Y (TTM)5.14%
Revenue growth 3Y23.86%
Revenue growth 5Y11.11%
Sales Q2Q%-0.28%
Revenue Next Year-2.37%
Revenue Next 2Y-6.02%
Revenue Next 3Y0.34%
Revenue Next 5Y4.5%
EBIT growth 1Y5.15%
EBIT growth 3Y52.37%
EBIT growth 5Y13.69%
EBIT Next Year6.33%
EBIT Next 3Y5.74%
EBIT Next 5Y5.78%
FCF growth 1Y-44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-5.12%
OCF growth 3Y-68.44%
OCF growth 5Y-50.28%